275111000001105: Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual medicinal product\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Pizotifen\Product containing only pizotifen in oral dose form (medicinal product form)\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Pizotifen\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Trade family\Sanomigran\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing pizotifen\Pizotifen\Product containing only pizotifen in oral dose form (medicinal product form)\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing pizotifen\Pizotifen\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing pizotifen\Product containing pizotifen in oral dose form (medicinal product form)\Product containing only pizotifen in oral dose form (medicinal product form)\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing pizotifen\Pizotifen\Product containing only pizotifen in oral dose form (medicinal product form)\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing pizotifen\Pizotifen\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing pizotifen\Product containing pizotifen in oral dose form (medicinal product form)\Product containing only pizotifen in oral dose form (medicinal product form)\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antimigraine agent (product)\Product containing pizotifen\Pizotifen\Product containing only pizotifen in oral dose form (medicinal product form)\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antimigraine agent (product)\Product containing pizotifen\Pizotifen\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antimigraine agent (product)\Product containing pizotifen\Product containing pizotifen in oral dose form (medicinal product form)\Product containing only pizotifen in oral dose form (medicinal product form)\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing pizotifen in oral dose form (medicinal product form)\Product containing only pizotifen in oral dose form (medicinal product form)\Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet\Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

17040901000001113 Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17041001000001116 Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has specific active ingredient	Pizotifen hydrogen malate	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has active ingredient	Analgesic	false	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has active ingredient	Pizotifen	false	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has active ingredient	Pizotifen hydrogen malate	false	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Sanomigran	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Pizotifen	false	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has specific active ingredient	Pizotifen hydrogen malate	false	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has basis of strength substance	Pizotifen	true	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has specific active ingredient	Pizotifen hydrogen malate	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets	Is pack of	False	Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier
Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets	Has AMP	True	Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
17040901000001113	Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
17041001000001116	Sanomigran 1.5mg tablets (Novartis Pharmaceuticals UK Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module